Top 3 Health Care Stocks You May Want To Dump This Quarter - Summit Therapeutics ( NASDAQ:SMMT ) , Certara ( NASDAQ:CERT )
As of April 15, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when ...
Third Harmonic Bio Stock Is Up 40% Monday: What's Happening? - Third Harmonic Bio ( NASDAQ:THRD )
Third Harmonic Bio's board approves and adopts a plan for the liquidation and dissolution of the company. The company estimates total shareholder distributions in the range of $246.6 million to $259.8 million, or $5.13 to $5.42 per share. Feel unsure about the market's next move?
Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Apple ( NASDAQ:AAPL ) , Best Buy Co ( NYSE:BBY )
U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Friday. Shares of Apple Inc. AAPL fell sharply in today's pre-market trading after the Trump administration announced tariff exemptions for smartphones. Apple shares gained 5.8% to 209.56 in the ...
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting of Stockholders on June ...
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
Recently presented THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria ...
Third Harmonic Bio, Inc. ( THRD ) Loses -31.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Third Harmonic Bio, Inc. (THRD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend ...
Third Harmonic Bio, Inc. ( THRD ) Upgraded to Buy: What Does It Mean for the Stock?
Third Harmonic Bio, Inc. (THRD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Down -39.61% in 4 Weeks, Here's Why You Should You Buy the Dip in Third Harmonic Bio, Inc. ( THRD )
The heavy selling pressure might have exhausted for Third Harmonic Bio, Inc. (THRD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend ...
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape - Third Harmonic Bio ( NASDAQ:THRD )
THB335 showed dose-dependent serum tryptase reductions from 13% to 84% at Day 15, supporting its advancement to Phase 2 in CSU. Third Harmonic Bio will halt non-THB335 research and cut 50% of its workforce while reviewing strategic options.
Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - NeuroPace ( NASDAQ:NPCE ) , Cogent Biosciences ( NASDAQ:COGT )
U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 0.1% on Tuesday. Shares of Acelyrin, Inc. SLRN fell sharply in today's pre-market trading. ACELYRIN announced additional Phase 2 data and the Phase 3 program design for lonigutamab in Thyroid Eye Disease.
Ingles Markets, Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session - American Coastal ( NASDAQ:ACIC ) , American Public Education ( NASDAQ:APEI )
U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Friday. Shares of Ingles Markets, Incorporated IMKTA fell in today's pre-market trading after the company reported results for the three and twelve months ended Sept. 28.
Wall Street Analysts Believe Third Harmonic Bio, Inc. ( THRD ) Could Rally 26.67%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Third Harmonic Bio, Inc. (THRD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the ...
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November - Third Harmonic Bio ( NASDAQ:THRD )
SAN FRANCISCO, Nov. 07, 2024 ( GLOBE NEWSWIRE ) -- Third Harmonic Bio, Inc. THRD, a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that management will participate in the ...
Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
THB335 Phase 1 SAD/MAD clinical trial progressing. study now on track to report clinical results in ...
Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference
SAN FRANCISCO, May 28, 2024 ( GLOBE NEWSWIRE ) -- Third Harmonic Bio, Inc. ( Nasdaq: THRD ) , a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and gastrointestinal inflammatory diseases, today announced that Chief Executive ...
Biogen ( BIIB ) Partner Begins Filing for Leqembi SC Autoinjector
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
U.S. FDA clears Investigational New Drug application for ...
AbbVie ( ABBV ) Boosts Neuropsychiatric Portfolio With New Deal
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
Theravance ( TBPH ) Q1 Earnings Top, Revenues Match Estimates
Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.
Intellia's ( NTLA ) Q1 Earnings & Revenues Beat Estimates
Intellia's (NTLA) earnings and revenues surpass estimates in the first quarter of 2024. The company provides developmental and regulatory updates on its pipeline candidates. Stock rises.
Mirum's ( MIRM ) Q1 Earnings & Revenues Fall Shy of Estimates
Mirum's (MIRM) earnings and revenues miss estimates in the first quarter of 2024. Livmarli drives year-over-year sales.
Beam Therapeutics ( BEAM ) Q1 Loss Narrows, Revenues Miss
Beam Therapeutics (BEAM) reports mixed first-quarter results. The company remains focused on pipeline development.
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
SAN FRANCISCO, March 28, 2024 ( GLOBE NEWSWIRE ) -- Third Harmonic Bio, Inc. ( Nasdaq: THRD ) , a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the appointment of Geoff McDonough, M.D., to its Board of Directors.
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
U.S. IND filed for THB335 with anticipated clinical trial start during ...
Are You Looking for a Top Momentum Pick? Why Third Harmonic Bio, Inc. ( THRD ) is a Great Choice
Does Third Harmonic Bio, Inc. (THRD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
On track to file a U.S. Investigational New Drug ( IND ) application for THB335 and initiate clinical studies in ...
Third Harmonic Bio Announces Leadership Changes - Third Harmonic Bio ( NASDAQ:THRD )
SAN FRANCISCO, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- Third Harmonic Bio, Inc. THRD, a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced the transition of Adrian S. Ray, Ph.D., from Chief Scientific Officer to Scientific Advisor, ...
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
SAN FRANCISCO, Aug. 31, 2023 ( GLOBE NEWSWIRE ) -- Third Harmonic Bio, Inc. ( Nasdaq: THRD ) , a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at ...
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
Introduced next-generation oral KIT inhibitor product candidate THB335, which retains the potency and selectivity of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution, and physicochemical profile ...
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335 - Third Harmonic Bio ( NASDAQ:THRD )
THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution and physicochemical profile THB001 demonstrated evidence of pharmacodynamic ( PD ) activity and clinical benefit in discontinued Phase 1b study in chronic inducible ...
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution and physicochemical profile ...
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases Company Progresses Preclinical Next-Generation oral KIT Inhibitor for Mast Cell-Mediated Inflammatory Diseases ...
Top 5 Health Care Stocks That May Rally - AstraZeneca ( NASDAQ:AZN ) , Amgen ( NASDAQ:AMGN )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
5 Cheapest Health Care Stocks You Should Think About
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
5 Cheapest Health Care Stocks You Should Think About - Baxter Intl ( NYSE:BAX ) , Cutera ( NASDAQ:CUTR )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Top 5 Health Care Stocks That May Surge - Graphite Bio ( NASDAQ:GRPH ) , Fate Therapeutics ( NASDAQ:FATE )
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.
Dow Dips Over 800 Points; S&P 500 Down 2.8% - Astria Therapeutics ( NASDAQ:ATXS ) , Crown Castle ( NYSE:CCI )
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 800 points. The Dow traded down 2.62% to 33,077.91 while the NASDAQ fell 3.45% to 10,785.29. The S&P 500 also fell, dropping, 2.80% to 3,883.40. Also check this: DSS And 3 Other Stocks Under $1 Insiders Are ...
Nasdaq Drops Over 300 Points; Crude Oil Down 1.5% - Altus Power ( NYSE:AMPS ) , Genie Energy ( NYSE:GNE )
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 300 points. The Dow traded down 2.09% to 33,256.29 while the NASDAQ fell 2.94% to 10,842.67. The S&P 500 also fell, dropping, 2.36% to 3,900.88. Also check this: DSS And 3 Other Stocks Under $1 Insiders ...
Why Harmonic Bio ( THRD ) Stock Is Plunging Today - Third Harmonic Bio ( NASDAQ:THRD )
Third Harmonic Bio Inc THRD will discontinue the ongoing Phase 1b study of THB001 in chronic inducible urticaria, after observing asymptomatic liver transaminitis in two subjects enrolled in the first dose cohort of 200mg BID.
Dow Tumbles Over 500 Points; ECB Raises Rates By 50 bps - Azure Power Global ( NYSE:AZRE ) , Genie Energy ( NYSE:GNE )
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 500 points after the Federal Reserve raised interest rates by 50 bps on Wednesday. Following the market opening Thursday, the Dow traded down 1.62% to 33,417.56 while the NASDAQ fell 1.97% to 10,951.28.
Novavax, Tesla, Western Digital And Some Other Big Stocks Moving Lower In Today's Pre-Market Session - Alight ( NYSE:ALIT ) , BioCryst Pharmaceuticals ( NASDAQ:BCRX )
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today's pre-market trading session. Novavax, Inc. NVAX shares fell 10% to $15.51 in pre-market trading. Novavax proposed an underwritten public offering to sell up to $125 million of its common stock.
Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Successfully Completed Upsized Initial Public Offering Providing Funding Through ...
These Bases, Breakouts And Buy Zones Offer Fresh Opportunities
Breakout Stocks Index Offers Fresh Opportunities In Netflix, Wingstop, Enphase And More Investor's Business Daily ...
New Stocks and Investor Ideas in Entertainment, Mining and Biotech ( CSE: GMNG ) ( CSE: PEK ) ( NasdaqGM: THRD )
New Stocks and Investor Ideas in Entertainment, Mining and Biotech ...
Tesla, ABB And Other Big Losers From Monday - ABB ( NYSE:ABB ) , AMC Entertainment ( NYSE:APE )
U.S. stocks closed sharply higher with the Dow Jones jumping more than 750 points on Monday. Here is the list of some big stocks recording losses in the previous session. Aura Biosciences, Inc. AURA fell 19.5% to close at $14.59.
Ryder System, Harrow Health And Other Big Gainers From Tuesday - Altus Power ( NYSE:AMPS ) , CVR Energy ( NYSE:CVI )
U.S. stocks closed mixed with the Dow Jones dropping around 125 points on Tuesday. Here is the list of some big stocks recording gains in the previous session. Grove Collaborative Holdings, Inc. GROV shares surged 35.5% to close at $4.01.
$11.5 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying - Freshworks ( NASDAQ:FRSH ) , DigitalBridge Group ( NYSE:DBRG )
Although US stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
$3.3 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying - Ivanhoe Electric ( AMEX:IE ) , Spok Holdings ( NASDAQ:SPOK )
Although US stocks closed higher on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
CAMBRIDGE, Mass., Sept. 19, 2022 ( GLOBE NEWSWIRE ) -- Third Harmonic Bio, Inc. ( Nasdaq: THRD ) , a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for the treatment of severe inflammatory diseases, today announced the closing of its initial ...
Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares - Third Harmonic Bio ( NASDAQ:THRD )
CAMBRIDGE, Mass., Sept. 19, 2022 ( GLOBE NEWSWIRE ) -- Third Harmonic Bio, Inc.
